133 related articles for article (PubMed ID: 37899242)
21. Serial scanning with technetium pyrophosphate (
Castaño A; DeLuca A; Weinberg R; Pozniakoff T; Blaner WS; Pirmohamed A; Bettencourt B; Gollob J; Karsten V; Vest JA; Chiuzan C; Maurer MS; Bokhari S
J Nucl Cardiol; 2016 Dec; 23(6):1355-1363. PubMed ID: 26453570
[TBL] [Abstract][Full Text] [Related]
22. Combination of Commonly Examined Parameters Is a Useful Predictor of Positive
Marume K; Takashio S; Nishi M; Hirakawa K; Yamamoto M; Hanatani S; Oda S; Utsunomiya D; Shiraishi S; Ueda M; Yamashita T; Sakamoto K; Yamamoto E; Kaikita K; Izumiya Y; Yamashita Y; Ando Y; Tsujita K
Circ J; 2019 Jul; 83(8):1698-1708. PubMed ID: 31189791
[TBL] [Abstract][Full Text] [Related]
23. Integrated diagnostic approach to wild-type transthyretin cardiac amyloidosis with the use of high-sensitivity cardiac troponin T measurement and
Ochi Y; Kubo T; Nakashima Y; Baba Y; Hirota T; Yamasaki N; Yamashita T; Ueda M; Ando Y; Kitaoka H
J Cardiol; 2020 Jan; 75(1):12-19. PubMed ID: 31324572
[TBL] [Abstract][Full Text] [Related]
24. Case of Biopsy-Proven Wild-Type ATTR Cardiac Amyloidosis With Abnormal CMR and Negative
Yabut J; Nadig V; Arora S; Hirsch D; Duvall WL
Circ Cardiovasc Imaging; 2024 Jan; 17(1):e015734. PubMed ID: 38146653
[No Abstract] [Full Text] [Related]
25. Usefulness of quantitative
Ogasawara K; Shiraishi S; Tsuda N; Sakamoto F; Oda S; Takashio S; Tsujita K; Hirai T
Jpn J Radiol; 2022 May; 40(5):508-517. PubMed ID: 34973114
[TBL] [Abstract][Full Text] [Related]
26. A case of disappearing amyloid on technetium pyrophosphate scan.
Wang A; Mahmood U; Tang X; Jain D; Pan S
J Nucl Cardiol; 2023 Oct; 30(5):1986-1991. PubMed ID: 37340232
[TBL] [Abstract][Full Text] [Related]
27. Microcalcification and
Mori A; Saito Y; Nakamura K; Iida T; Akagi S; Yoshida M; Taniyama M; Miyoshi T; Ito H
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768243
[TBL] [Abstract][Full Text] [Related]
28. Technetium pyrophosphate myocardial uptake and peripheral neuropathy in a rare variant of familial transthyretin (TTR) amyloidosis (Ser23Asn): a case report and literature review.
Castaño A; Bokhari S; Brannagan TH; Wynn J; Maurer MS
Amyloid; 2012 Mar; 19(1):41-6. PubMed ID: 22149423
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic and prognostic value of Technetium-99m pyrophosphate uptake quantitation for transthyretin cardiac amyloidosis.
Miller RJH; Cadet S; Mah D; Pournazari P; Chan D; Fine NM; Berman DS; Slomka PJ
J Nucl Cardiol; 2021 Oct; 28(5):1835-1845. PubMed ID: 33689152
[TBL] [Abstract][Full Text] [Related]
30.
Tahara N; Lairez O; Endo J; Okada A; Ueda M; Ishii T; Kitano Y; Lee HE; Russo E; Kubo T
ESC Heart Fail; 2022 Feb; 9(1):251-262. PubMed ID: 34841715
[TBL] [Abstract][Full Text] [Related]
31. Non-cardiac uptake of technetium-99m pyrophosphate in transthyretin cardiac amyloidosis.
Sperry BW; Gonzalez MH; Brunken R; Cerqueira MD; Hanna M; Jaber WA
J Nucl Cardiol; 2019 Oct; 26(5):1630-1637. PubMed ID: 29344917
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous Tc-99m PYP/Tl-201 dual-isotope SPECT myocardial imaging in patients with suspected cardiac amyloidosis.
Tamarappoo B; Otaki Y; Manabe O; Hyun M; Cantu S; Arnson Y; Gransar H; Hayes SW; Friedman JD; Thomson L; Slomka P; Dey D; Vescio R; Patel J; Berman DS
J Nucl Cardiol; 2020 Feb; 27(1):28-37. PubMed ID: 31172386
[TBL] [Abstract][Full Text] [Related]
33. Bilateral Multiple Fractures Obstruct Quantitation of 99m Tc-Pyrophosphate Imaging for Cardiac Amyloidosis.
Zhou Q; Zuo J; Xiao L; Jiang L; Zhao Z
Clin Nucl Med; 2024 Jul; 49(7):e362-e363. PubMed ID: 38651782
[TBL] [Abstract][Full Text] [Related]
34. Transthyretin amyloid cardiomyopathy disease burden quantified using
Watanabe S; Nakajima K; Toshima F; Wakabayashi H; Yoshida S; Yoneyama H; Komatsu J; Konishi T; Kinuya S
J Nucl Cardiol; 2023 Dec; 30(6):2721-2735. PubMed ID: 37605060
[TBL] [Abstract][Full Text] [Related]
35. Iatrogenic intramuscular hematoma of the oblique muscles as a complication of technetium-99m-labeled pyrophosphate imaging-based computed tomography-guided core-needle biopsy in a patient with wild-type transthyretin cardiac amyloidosis.
Takahashi K; Iwamura T; Hiratsuka Y; Sasaki D; Yamamura N; Ueda M; Yoshino M; Enomoto D; Morioka H; Uemura S; Okura T; Sakaue T; Ikeda S
Radiol Case Rep; 2024 Jan; 19(1):330-340. PubMed ID: 38028290
[TBL] [Abstract][Full Text] [Related]
36. Comparison of 1-h with 3-h planar
Saitou T; Aikawa T; Manabe O; Nagase A; Kudo T; Oyama-Manabe N
Ann Nucl Med; 2023 Feb; 37(2):99-107. PubMed ID: 36352186
[TBL] [Abstract][Full Text] [Related]
37. Light Chain Testing Abnormalities Among Patients With Transthyretin Amyloid Cardiomyopathy Referred for Technetium-99m Pyrophosphate Imaging.
Alreshq R; Cozzolino M; Lilleness B; Pipilas A; Mendelson L; Joshi T; Muralidhar V; Guardino E; Berk JL; Siddiqi OK; Gopal DM; Sanchorawala V; Ruberg FL
Am J Cardiol; 2022 Oct; 181():105-112. PubMed ID: 36028388
[TBL] [Abstract][Full Text] [Related]
38. Inter-observer reproducibility and intra-observer repeatability in
Singh V; Cuddy S; Kijewski MF; Park MA; Taylor A; Taqueti VR; Skali H; Blankstein R; Falk RH; Di Carli MF; Dorbala S
J Nucl Cardiol; 2022 Apr; 29(2):440-446. PubMed ID: 32918247
[TBL] [Abstract][Full Text] [Related]
39. Volumetric evaluation of
Watanabe S; Nakajima K; Wakabayashi H; Yoneyama H; Yoshida S; Komatsu J; Konishi T; Inaki A; Kinuya S
J Nucl Cardiol; 2022 Dec; 29(6):3102-3110. PubMed ID: 34907500
[TBL] [Abstract][Full Text] [Related]
40. Transthyretin Cardiac Amyloidosis as Diagnosed by 99mTc-PYP Scanning in Patients with Acute Heart Failure and Preserved Ejection Fraction.
Lo Presti S; Horvath SA; Mihos CG; Rajadhyaksha C; McCloskey V; Santana O
Crit Pathw Cardiol; 2019 Dec; 18(4):195-199. PubMed ID: 31725511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
